medical professionals looking at computer screens with data on it
21 September
On
In Press Releases

Source: Created with Gemini; Copyright: N/A (AI generated image); License: Public Domain (CC0) A new study explores how customizing AI can safely guide doctors in making better, more accurate patient diagnoses. (Toronto, September 21, 2026) Harnessing generative AI to help doctors make critical medical decisions requires more than just raw technology. A new review study in the Journal of Medical Internet Research published by JMIR Publications shows that adapting existing language models is the key to ensuring they can safely and effectively assist with clinical diagnoses, patient triaging, and treatment planning in real-world health care settings. The research team, led by Anshum Patel, MD, andRead More →

A visual abstract summarizing the key findings of the research titled "Digital Behavioral Infrastructure for Glucagon-Like Peptide-1 Pharmacotherapy: Viewpoint on Persistence, Tolerability, and Postcessation Durability," published in the Journal of Medical Internet Research in 2026. The study found that GLP-1 companion digital support may help translate GLP‑1 therapy into durable behavioral and environmental change.
09 September
On
In Press Releases
Tagged , , , , , , , ,

Source: Image created by JMIR Publications/Authors; Copyright: JMIR Publications; License: Creative Commons Attribution (CC-BY) New paper highlights the need for integrated digital behavioral support, proposing a “habit window hypothesis” and associated research agenda to maximize the long-term success of GLP-1 therapies. (Toronto, September 9, 2026) Glucagon-like peptide-1 (GLP-1) medications have revolutionized weight management, yet high dropout rates and rapid weight regain remain significant hurdles for many patients. A new viewpoint paper published in the Journal of Medical Internet Research highlights a fundamental challenge: medication alone is not enough to secure long-term behavioral change. In the paper titled “Digital Behavioral Infrastructure for Glucagon-Like Peptide-1 Pharmacotherapy: Viewpoint onRead More →